SKIN
The Beauty Health CompanyNASDAQConsumer Defensive$0.91-2.40%ClosedMarket Cap: $115.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.86
P/S
0.38
EV/EBITDA
6.97
DCF Value
$-14.43
FCF Yield
31.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
65.3%
Operating Margin
-6.9%
Net Margin
-3.2%
ROE
-15.4%
ROA
-1.9%
ROIC
-4.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $82.4M | 64.3% | $200.0K | $-8.1M | $-0.06 | — |
| FY 2025 | $300.8M | 65.3% | $-20.8M | $-9.5M | $-0.16 | — |
| Q3 2025 | $70.7M | 64.6% | $-6.2M | $-11.0M | $-0.09 | — |
| Q2 2025 | $78.2M | 62.8% | $-2.7M | $19.7M | $0.03 | — |
| Q1 2025 | $69.6M | 69.8% | $-12.0M | $-10.1M | $-0.08 | — |
| Q4 2024 | $83.5M | 62.7% | $-7.2M | $-10.3M | $-0.08 | — |
| FY 2024 | $334.3M | 54.5% | $-67.8M | $-29.1M | $-0.36 | — |
| Q3 2024 | $78.8M | 51.6% | $-21.5M | $-18.3M | $-0.15 | — |
| Q2 2024 | $90.6M | 45.2% | $-22.1M | $202.0K | $-0.10 | — |
| Q1 2024 | $81.4M | 59.4% | $-17.0M | $-679.0K | $-0.10 | — |
| Q4 2023 | $96.8M | 47.2% | $-18.4M | $-9.4M | $-0.07 | — |
| FY 2023 | $398.0M | 39.0% | $-130.9M | $-100.1M | $-0.76 | — |